The global pain management devices market was valued at USD 8.4 billion in 2025 and is projected to reach USD 16.8 billion by 2033, expanding from USD 9.2 billion in 2026 at a CAGR of 8.9% from 2026 to 2033. North America dominated the market in 2025, accounting for a 47.5% revenue share. The increasing prevalence of chronic diseases, musculoskeletal disorders, obesity, and trauma-related conditions is driving demand for advanced pain management devices worldwide.

Pain Management Devices Market Overview

The market is expanding as healthcare providers and patients increasingly seek effective alternatives for managing chronic and acute pain. Growing incidences of diabetes, obesity, arthritis, osteoarthritis, neuropathic pain, and other chronic conditions are increasing the need for nerve stimulation, neuromodulation, radiofrequency ablation, and other pain management technologies.

Technological advancements in minimally invasive procedures and the growing preference for treatments that can reduce hospitalization time are also supporting market growth.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

Key Market Highlights

• 2025 market size: USD 8.4 billion
• 2026 estimated market size: USD 9.2 billion
• 2033 projected market size: USD 16.8 billion
• CAGR, 2026–2033: 8.9%
• Largest region: North America
• North America revenue share, 2025: 47.5%
• Leading product segment: Neurostimulation products
• Leading application segment: Neuropathic pain
• Leading end-use segment: Hospitals & clinics

Go Deeper! Ask Prism AI

about the Global pain management devices market. Get instant answers to questions related to market sizing, growth drivers & their impact, and more.

Key Market Trends & Insights

Neurostimulation Products Lead the Market

The neurostimulation products segment accounted for the largest share of the pain management devices market, representing 57.8% of revenue in 2025. Growing demand for non-pharmacological approaches to chronic pain management and advancements in neuromodulation technologies are supporting segment growth.

Neuropathic Pain Represents the Leading Application

The neuropathic pain segment held the largest application share at 32.1% in 2025. The increasing prevalence of diabetes, nerve-related disorders, and other chronic conditions associated with neuropathic pain is contributing to demand for targeted pain management solutions.

Hospitals & Clinics Remain the Leading End Use

The hospitals & clinics segment accounted for 29.8% of the market in 2025. Hospitals and specialty clinics increasingly adopt advanced pain management technologies to support minimally invasive procedures and improve treatment outcomes.

Download a free sample report or claim your copy of this full market intelligence report

Regional Insights

North America Dominates the Pain Management Devices Market

North America held the largest regional position, accounting for 47.5% of global revenue in 2025. The region benefits from a high prevalence of chronic diseases, advanced healthcare infrastructure, strong adoption of innovative medical technologies, and the presence of leading pain management device manufacturers.

The U.S. held the largest country-level market share in 2025, supported by increasing demand for advanced pain therapies and continued technological development in neuromodulation and minimally invasive pain treatment.

Pain Management Devices Market Size & Forecast

Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs.

Key Growth Drivers

Rising Prevalence of Chronic Diseases

The growing incidence of chronic and lifestyle-related diseases is a major factor supporting the expansion of the pain management devices market. Conditions such as diabetes and obesity can contribute to nerve and musculoskeletal disorders, increasing demand for nerve and muscle stimulation technologies.

Hypertension is another important health concern associated with chronic conditions and complications that can require long-term pain management. According to WHO data for 2024, approximately one in three adults worldwide has hypertension, with prevalence increasing substantially among older adults.

Increasing Burden of Musculoskeletal Disorders

The rising prevalence of osteoarthritis, rheumatoid arthritis, orthopedic degenerative diseases, and other musculoskeletal conditions is increasing the global burden of chronic pain. These conditions can restrict mobility and interfere with everyday activities, creating greater demand for effective pain management technologies.

Research published in 2024 indicates that osteoarthritis affects approximately 7.6% of the global population, with prevalence expected to increase substantially by 2050. The growing burden of osteoarthritis, particularly among older populations, is expected to support demand for pain management devices.

Obesity and Arthritis Increase Demand for Pain Therapies

The global increase in obesity is contributing to the prevalence of arthritis and other musculoskeletal disorders. Findings released by the NCD Risk Factor Collaboration in 2024 indicated that more than one billion people worldwide were living with obesity, including approximately 880 million adults and 159 million children and adolescents aged 5 to 19.

The relationship between excess body weight and joint stress further increases the need for pain management interventions. As a result, healthcare providers and patients are increasingly exploring device-based treatment options alongside conventional therapies.

Limitations of Pharmacological Pain Management

The limitations and side effects associated with long-term use of certain pain medications are encouraging interest in alternative approaches. Pain management devices can provide non-pharmacological or minimally invasive treatment options for patients who require long-term pain relief.

The growing preference for personalized treatment, combined with concerns regarding medication-related adverse effects and inadequate response to conventional therapies in some patients, is creating opportunities for device-based pain management solutions.

Demand for Shorter Hospital Stays and Cost-Efficient Care

Healthcare systems are increasingly focused on reducing treatment costs, hospital stays, and the overall burden on healthcare infrastructure. Minimally invasive pain management procedures can support outpatient or shorter-duration treatment pathways in appropriate cases.

The high cost of hospitalization further strengthens the need for efficient treatment models. For example, an article published in March 2023 estimated the average daily hospitalization cost in the U.S. at approximately USD 2,883, with an average stay of around 4.6 days, resulting in an estimated average hospitalization expense of approximately USD 13,262.

Competitive Landscape

Leading companies in the pain management devices market are focusing on product innovation, strategic partnerships, mergers and acquisitions, portfolio expansion, and geographic expansion to strengthen their market positions.

Companies are also investing in advanced neuromodulation technologies, minimally invasive treatment solutions, and next-generation pain management systems to address the growing demand for effective chronic pain therapies.

Key Pain Management Devices Companies

The major companies profiled in the pain management devices market include:

• B. Braun Melsungen AG
• Baxter
• Boston Scientific Corporation
• Nevro Corp.
• Enovis
• OMRON Healthcare, Inc.
• Medtronic
• ICU Medical, Inc.

Explore our dedicated business services:

U.S. Healthcare Facility Mapping & Intelligence Platform: Get facility-level intelligence to guide smarter decisions. Sign up Today